Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalidomide use: past history and current implications for practice.

D A Goldman1

  • 1Cancer Institute of New Jersey, New Brunswick, USA.

Oncology Nursing Forum
|May 8, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference.

European radiology·2015
Same author

Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery.

European radiology·2015
Same author

Volume and landmark analysis: comparison of MRI measurements obtained with an endorectal coil and with a phased-array coil.

Clinical radiology·2015
Same author

Lack of association between the T-->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia.

Schizophrenia research·2001
Same author

Are standardized mortality ratios valid for public health data analysis?

Statistics in medicine·2000
Same author

Language differences in interpretation of breast cancer health messages.

Journal of cancer education : the official journal of the American Association for Cancer Education·1999

Thalidomide, once known for severe birth defects, is returning for cancer treatment. Nurses play a crucial role in educating patients to prevent risks and manage side effects effectively.

Area of Science:

  • Pharmacology
  • Teratology
  • Oncology

Background:

  • Thalidomide's history is marked by severe teratogenic effects leading to birth defects in the 1960s.
  • A resurgence in thalidomide use is observed in oncology, particularly for multiple myeloma treatment.
  • Public and professional fear persists due to its historical association with birth defects.

Purpose of the Study:

  • To review the historical context of thalidomide.
  • To examine contemporary fears surrounding its renewed use.
  • To elucidate the critical role of nurses in patient education regarding thalidomide.

Main Methods:

  • Review of published articles, abstracts, and books.
  • Inclusion of clinical experience.
  • Literature search focused on nursing publications related to thalidomide.

Related Experiment Videos

Main Results:

  • Thalidomide's teratogenic effects caused widespread birth defects when used as a sedative.
  • Thalidomide is now being reconsidered for oncologic indications, notably multiple myeloma.
  • Patient education is identified as key to mitigating fear and preventing adverse outcomes.

Conclusions:

  • Nurses are essential in educating patients about thalidomide to prevent birth defects and manage side effects.
  • Despite its history, thalidomide can be used safely with comprehensive patient monitoring and education.
  • Limited nursing literature on thalidomide necessitates increased focus on this educational role.